KeyBanc raised the firm’s price target on Revvity (RVTY) to $145 from $132 and keeps an Overweight rating on the shares. The firm notes that having pre-announced Q4 in mid-January, all eyes were on the company’s guidance/commentary for FY25 and the company delivered a positive message. While the stock opened down due to a reduction in margin expected in Q1, KeyBanc points out that this is being driven by a decision to increase strategic investment. The firm believes that reagents, where Revvity has been gaining share, are one component of this investment, and sees the potential for this business to outperform.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RVTY:
Questions or Comments about the article? Write to editor@tipranks.com